Model Course ePortfolios
BME 441.01, Senior Design Project in Biomedical Engineering, Spring 2011
Introduction to product development from the perspective of solving biomedical, biotechnological, environmental, and ergonomic problems. Teamwork in design, establishing customer needs, writing specifications, and legal and financial issues are covered in the context of design as a decision-based process. A team design project provides the opportunity to apply concepts covered in class. Formulation of optimal design problems in biomedical and physiological settings. Introduces optimization techniques for engineering design and modeling for compact and rapid optimization of realistic biomedical engineering problems. 3 credits.
Instructor: Dr. Jonathan Liu
ePortoflios are a requirement for course completion.
Dr. Liu will join Dr. Gary Halada and Dr. Imin Kao and represent the Department of Engineering in the Making Connections - Connecting to Learning project involving integrative learning and eportfolios. They also have applied for a NSF grant for developing a problem-based learning model which includes the eportfolio process. For more information on eportfolios and the project, contact Nancy Wozniak in The Faculty Center, ext. 22780. firstname.lastname@example.org
View: Lab on a chip
Few words from the e-Portfolio.....
Tuberculosis (mycobacterium tuberculosis) can be found in nearly 2 billion people worldwide. According to the World Health Organization, only 5-10% of people infected with tuberculosis show recognizable symptoms. The inactive form of tuberculosis can still be spread through the air and hence, non-symptomatic individuals can unknowingly infect others. Untreated hosts carrying tuberculosis will on average infect 10-15 people in one year. Africa and Southeast Asia combine for 65% of the total 9.4 million new cases of TB in 2009. In Africa, tuberculosis is particularly dangerous due to the high rates of HIV prevalence in TB cases. Nearly 2 million people die every year from tuberculosis despite its being fully treatable. In order to effectively reduce the prevalence of tuberculosis in these areas, we must be able to treat the disease faster than it spreads. This is a multistep process that necessitates population screening for the presence of the tuberculosis bacteria, followed by containment and treatment. Our company is proposing a device that can detect tuberculosis bacteria with high sensitivity and at a low cost per individual tested. This device is intended to be used in the screening process to test large populations. Current detection methods require at least 24-48 hours to give positive results. In the highest prevalence countries, full diagnosis is too time consuming and expensive. With our device, agencies like World Health Organization will be able to filter the population requiring diagnosis for tuberculosis down to a manageable size.